Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments
Kisoboka
Kisoboka: Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments
2 other identifiers
interventional
716
1 country
1
Brief Summary
The investigators developed the Kisoboka ("It is possible") Intervention to address limitations of existing evidence-based interventions to optimize treatment as prevention among men living with HIV who drink alcohol at hazardous levels in "risk environments" such as fishing communities through reductions in hazardous alcohol use, improved adherence to HIV medications and achieving undetectable HIV viral loads. Social and structural determinants unique to fishing communities interact to create a risk environment where hazardous drinking impedes adherence to HIV medications among men living with HIV, including prevalent social norms of drinking, drinking as a way of experiencing "reward" and connecting with others (e.g. in the context of transactional sex), stressful work conditions, a "live for today" outlook, and a cash-based economy with no traditional savings infrastructure leading to ease of daily expenditure on drinking and sex work. These social and environmental conditions result in high levels of alcohol misuse and HIV risk, poor HIV outcomes, and exacerbation of HIV-associated wellness comorbidities such as poor mental and subjective physical health and food insecurity. The goal of this study is to learn if the intervention called Kisoboka works to help men in fishing communities reduce hazardous alcohol use, be better able to take the participants HIV medication as prescribed, and have undetectable HIV viral loads. The investigators will compare the Kisoboka intervention to a brief alcohol screening, adherence counseling, and referrals, and to components of the Kisoboka intervention. Participants will attend intervention counseling sessions according to the study arm to which the participants are randomly assigned. The number of sessions ranges from 1 to 6 over 1 to 16 weeks and are individual only or both individual and group sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2025
CompletedFirst Posted
Study publicly available on registry
January 13, 2025
CompletedStudy Start
First participant enrolled
June 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2029
June 17, 2025
June 1, 2025
3.3 years
January 9, 2025
June 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Phosphatidylethanol (PEth) From Baseline
alcohol biomarker which correlates well with the volume of alcohol consumed over the prior 2-4 weeks
6 and 12 month follow up
Number of Participants with very Hazardous Alcohol Use at Baseline, 6, and 12 Month Follow up
Combined biomarker self-report outcome. Number of participants with phosphatidylethanol values ≥400ng/mL OR AUDIT-C scores ≥9. AUDIT-C is the Alcohol Use Disorder Identification Test - Concise.
6 and 12 month follow up
Number of Participants With Optimal Antiretroviral (ART) Adherence at Baseline, 6 and 12 Month Follow up
ART levels tested using blood biomarkers with cut points indicating 6 or more doses per week
6 and 12 month follow up
Number of Participants with Undetectable HIV Viral Loads at baseline, 6, and 12 month follow up
HIV viral load laboratory test results showing undetectable viral load per the assay used (e.g., \<20, \<40 copies/ml)
6 and 12 month follow up
Secondary Outcomes (4)
Change in depressive symptoms from baseline
6 and 12 month follow up
Number of participants with optimal self-reported Antiretroviral Adherence at Baseline, 6 and 12 months
6 and 12 month follow up
Change in subjective physical health from baseline
6 and 12 month follow up
Number of participants who are food secure at baseline, 6 months, and 12 months
6 and 12 month follow up
Other Outcomes (4)
Change in delayed reward discounting from baseline
6 and 12 month follow up
Change in endorsement of alternative reinforcers from baseline
6 and 12 month follow up
Change from baseline in endorsement of the reward value of alcohol
6 and 12 month follow up
- +1 more other outcomes
Study Arms (4)
Kisoboka (BE + MI and synergy)
EXPERIMENTALBehavioral Economics (BE)
EXPERIMENTALMotivational Interviewing (MI)
EXPERIMENTALScreening and Referral (S&R)
ACTIVE COMPARATORInterventions
Intervention activities: Financial goal setting (developing delayed rewards), Text message reminders of savings goals (increase salience of delayed rewards), Substance-free activities (alternative reinforcers), Mobile money savings and work payments (constraints on buying alcohol), Social support \& role models for financial goals and substance-free activities (delayed rewards, alternative reinforcers), Financial literacy, Develop motivation \& confidence for change, Goal setting for alcohol reduction \& ART adherence, Alcohol harms \& defining low risk drinking Discuss challenges to change and maintain alcohol risk reduction and improved adherence, Developing \& reinforcing discrepancy between savings/life goals and drinking/poor adherence, Developing discrepancy activity: goals for savings and healthy living and weekly, monthly, yearly spending on alcohol Self-monitoring of savings \& spending Text message reminders to reinforce discrepancy between unhealthy behavior \& goals
Intervention activities: Financial goal setting (developing delayed rewards), Text message reminders of savings goals (increase salience of delayed rewards), Substance free activities (alternative reinforcers), Mobile money savings and work payments (constraints on buying alcohol/ decrease reward value of alcohol), Social support \& role models for financial goals and substance free activities (delayed rewards, alternative reinforcers), Financial literacy
Intervention activities: Develop motivation and confidence for change, Specific goal setting for alcohol reduction and ART adherence, Alcohol harms \& defining low risk drinking, Discuss challenges to change and to maintain alcohol risk reduction and improved adherence/care engagement
Brief feedback on their Alcohol Use Disorders Identification Test (AUDIT) score per the AUDIT brief intervention manual, a referral for alcohol counseling, and brief guidance on the importance of HIV care engagement and adherence following the Ugandan Ministry of Health protocol. A referral coupon with details of the clinic name and location will be provided to each participant and participants will be asked to submit the referral note to the "alcohol and/or HIV counselor".
Eligibility Criteria
You may qualify if:
- living with HIV;
- residing in a fishing community (on most days/nights);
- AUDIT-C positive (≥4) indicating potential hazardous drinking;
- \>6 months since initial antiretroviral treatment (ART) initiation;
- not planning to move from the area within the next 6 months;
- have their own mobile phone and can be reached via phone.
- an indicator of potential suboptimal treatment as prevention (TasP) either:
- (i) last HIV viral load test (within 6 months) was detectable (\>20) or (ii) last viral load test between 6 and 13 months ago was detectable (\>20) and reports missing ≥2 ART doses in the past 2 weeks or (iii) a lack of viral load test results for the prior 13 months in clinic records and reports missing ≥2 ART doses in the past 2 weeks;
You may not qualify if:
- visibly intoxicated at enrollment (eligible to enroll when not intoxicated);
- does not speak Luganda or English;
- currently receiving a majority of work payments via mobile money/digital payments;
- participated in the Kisoboka pilot RCT;
- unable to read basic Luganda or English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- San Diego State Universitylead
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator
- Makerere University Walter Reed Programcollaborator
- Makerere Universitycollaborator
Study Sites (1)
Makerere University Walter Reed Program
Kampala, Uganda
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan M Kiene, PhD, MPH
San Diego State University
- PRINCIPAL INVESTIGATOR
Joseph KB Matovu, PhD, MHS
Makerere University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2025
First Posted
January 13, 2025
Study Start
June 16, 2025
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
February 1, 2029
Last Updated
June 17, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Baseline data, such as demographics and self-reported data, that require no additional analyses will be submitted to the NIAAA Data Archive repository within 4 months after enrollment. Baseline laboratory test data will be added as it becomes available. After the study is complete and unmasked, the study team will submit all remaining data (follow-up data). Data will be shared with the general research community at the time of an associated publication, or the end of the award/support period, whichever comes first. As required by NIAAA Data Archive repository, for each publication developed, the investigators will also create studies that contain the data used in that analysis and include the digital object identifiers (DOI) for that study (from NIAAA Data Archive repository) in the manuscript to aid in findability. NIAAA Data Archive repository makes determinations regarding how long to preserve the data; to date files have been preserved in perpetuity.
- Access Criteria
- Data will be findable for the research community through the NIMH Data Archive (NIAAA Data Archive specifically) which is established at the time of study funding. For all publications, an NIAAA Data Archive study will be created. Each of those studies is assigned a digital object identifier (DOI). This data DOI will be referenced in the publication. Investigators at institutions with a Federal Wide Assurance (FWA) will be able to gain access to NIAAA Data Archive repository data by submitting a data access request in accordance with applicable NIAAA Data Archive repository policies. Data requests will be reviewed and granted by an NIMH/NIAAA Data Archive Data Access Committee.
The investigators will share raw questionnaire data. For all data, all identifiable information will be removed and maintained in a secure file for future contact purposes, but Global Unique Identifiers (GUIDs) or pseudoGUIDs will be assigned through the National Institute of Mental Health (NIMH) Data Archive. All other de-identified scientific data (questionnaire datasets, results from biological specimens testing, will be both preserved and shared through NIAAA Data Archive repository. Study protocol for the randomized controlled trial and survey questionnaires will be made available through NIAAA Data Archive repository. This documentation will be provided in portable document format (PDF). Scientific data will be processed and analyzed in standard statistical analysis software (e.g., SPSS, MPLUS, SAS, and R).